Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

NCT00346229 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
DRUG: lyso-thermosensitive liposomal doxorubicin(Thermodox)
PROCEDURE: hyperthermia treatment

Sponsor

Duke University

Collaborators

[object Object]